Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2025-12-27 @ 10:14 PM
Study NCT ID:
NCT00727961
Status:
COMPLETED
Last Update Posted:
2017-06-08
First Post:
2008-06-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2008-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-23
First Submit QC Date:
None
Study First Post Date:
2008-08-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-01-29
Results First Submit QC Date:
None
Results First Post Date:
2009-07-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-12
Last Update Post Date:
2017-06-08
Last Update Post Date Type:
ACTUAL